Leo, M.; Schmitt, L.-I.; Küsterarent, P.; Kutritz, A.; Rassaf, T.; Kleinschnitz, C.; Hendgen-Cotta, U.B.; Hagenacker, T.
Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons. Int. J. Mol. Sci. 2020, 21, 8636.
https://doi.org/10.3390/ijms21228636
AMA Style
Leo M, Schmitt L-I, Küsterarent P, Kutritz A, Rassaf T, Kleinschnitz C, Hendgen-Cotta UB, Hagenacker T.
Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences. 2020; 21(22):8636.
https://doi.org/10.3390/ijms21228636
Chicago/Turabian Style
Leo, Markus, Linda-Isabell Schmitt, Patricia Küsterarent, Andrea Kutritz, Tienush Rassaf, Christoph Kleinschnitz, Ulrike B. Hendgen-Cotta, and Tim Hagenacker.
2020. "Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons" International Journal of Molecular Sciences 21, no. 22: 8636.
https://doi.org/10.3390/ijms21228636
APA Style
Leo, M., Schmitt, L.-I., Küsterarent, P., Kutritz, A., Rassaf, T., Kleinschnitz, C., Hendgen-Cotta, U. B., & Hagenacker, T.
(2020). Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons. International Journal of Molecular Sciences, 21(22), 8636.
https://doi.org/10.3390/ijms21228636
